NASDAQ
MiNK Therapeutics, Inc. (INKT) has a free cash flow growth of -83449.83% as of Friday, May 29, 2026. This represents a 330.75% decrease compared to its 12-month average of -19373.09%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.